Client: Complement Therapeutics
Turning powerful new Complement System insights ninto innovative treatments
Complement Therapeutics is a biotechnology company undertaking innovative research into diseases related to the body’s Complement System, in particular Geographic Atrophy.
Geographic Atrophy is a chronic and progressive eye condition that eventually culminates in blindness. Currently there is no available treatment.
The company is a spinout from The University of Manchester. It was founded by Professor Paul Bishop, Professor Simon J. Clark and Dr Richard Unwin, who have international reputations and world-leading Complement System expertise.
HTP were briefed by the founders to develop a website that would help attract funding to pursue further research and at the same time educate and inform visitors about Complement System diseases – especially Geographic Atrophy – and the potential of the company’s work to benefit the lives of millions.
Client: Complement Therapeutics
Turning powerful new Complement System insights into innovative treatments
Complement Therapeutics is a biotechnology company undertaking innovative research into diseases related to the body’s Complement System, in particular Geographic Atrophy.
Geographic Atrophy is a chronic and progressive eye condition that eventually culminates in blindness. Currently there is no available treatment.
The company is a spinout from The University of Manchester. It was founded by Professor Paul Bishop, Professor Simon J. Clark and Dr Richard Unwin, who have international reputations and world-leading Complement System expertise.
HTP were briefed by the founders to develop a website that would help attract funding to pursue further research and at the same time educate and inform visitors about Complement System diseases – especially Geographic Atrophy – and the potential of the company’s work to benefit the lives of millions.
